Virally Encoded Chemokine Binding Proteins

Overview

Journal Mini Rev Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2005 Sep 24

PMID 16178725

Citations 8

Authors

Louise M C Webb

Antonio Alcami

Affiliations

Soon will be listed here.

Abstract

Virus-encoded immune evasion mechanisms provide information on viral pathogenesis and offer a unique opportunity to identify new strategies of immune modulation. Secreted proteins that bind a broad range of chemokines have been identified in recent years in poxviruses and herpesviruses. We discuss the properties of these viral chemokine inhibitors and their potential as new therapeutics to treat human inflammatory diseases.

Citing Articles

Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.

Baker L, Chitas A, Hartley C, Coppo M, Vaz P, Stent A PLoS One. 2014; 9(5):e96563.

PMID: 24794215 PMC: 4008605. DOI: 10.1371/journal.pone.0096563.

The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.

Hewit K, Fraser A, Nibbs R, Graham G J Biol Chem. 2014; 289(18):12330-42.

PMID: 24644289 PMC: 4007430. DOI: 10.1074/jbc.M113.534545.

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Lee H, Lee S, Chaudhary P, Gill P, Jung J Future Microbiol. 2010; 5(9):1349-65.

PMID: 20860481 PMC: 3076960. DOI: 10.2217/fmb.10.105.

Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Flad H, Brandt E Cell Mol Life Sci. 2010; 67(14):2363-86.

PMID: 20213276 PMC: 11115602. DOI: 10.1007/s00018-010-0306-x.

Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Novak M, Bryers J, Reichert W Biomaterials. 2009; 30(11):1989-2005.

PMID: 19185345 PMC: 2673477. DOI: 10.1016/j.biomaterials.2008.11.025.